Faculty Bibliography

Introduction: Femoral artery closure devices allow for earlier mobilization and improved comfort for patients after vascular access. The Mynx device (Cardinal Health, Inc.) is an extravascular closure device that deploys a polyethylene glycol plug, and is maximally labeled for 6/7 French sheath closure. Here we report our experience using the device to close 8F sheaths in patients post endovascular treatment of ischemic stroke. Methods: We performed a retrospective analysis of all stroke cases where the 6/7F Mynx device was used with 8F sheaths. Operating room flowsheets, physician and nursing notes up to 2 weeks post angiography were reviewed and data on deployment and complications were analyzed. Results: 87 consecutive stroke embolectomy cases at an academic center were reviewed from 2014 through 2016. 8F short sheaths were utilized in 23 patients, and all 23 were closed with 6/7F Mynx device. Average compression time following Mynx deployment was 18 minutes. The mean patient age was 70.7 years. The average BMI was 27. Ten patients (38%) had received IV tPA; 6 patients were on anticoagulation(27%); and 2 patients had coagulapathies. Two (8%) patients had documented groin bruising post Mynx; both resolved spontaneously. No patients had loss of ipsilateral distal pulses post mynx; in 1 patient, distal pulses changed from palpable to dopplerable. No patient had significant pain or swelling at the site. There were no groin site infections. Conclusions: Off-Label use of 6/7F Mynx for 8F closure is safe and efficacious, and was not associated with an increased complication rate in our small cohort

Patients with dementias commonly experience neuropsychiatric symptoms that diminish their quality of life. Pharmacologic treatments for these symptoms are limited in their efficacy. In the absence of near-future prospects for a cure for degenerative dementias, treatments that improve neuropsychiatric symptoms and quality of life are needed. We explore the hypothesis that art therapy is useful in dementia by reviewing the extant literature. With appropriate structure, patients with dementia can produce and appreciate visual art. Case studies and several small trials suggest that art therapy engages attention, provides pleasure, and improves neuropsychiatric symptoms, social behavior, and self-esteem. Whether these benefits generalize beyond the studio remains unknown. We offer a theoretical framework that motivates the use of art therapy and propose that clinical enquiry to establish methods, assess efficacy, and define optimal conditions for the use of art therapy in Alzheimer's and other dementing disorders is timely.